As of 2024-10-09, the Intrinsic Value of Eli Lilly and Co (LLY) is
284.51 USD. This LLY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 913.72 USD, the upside of Eli Lilly and Co is
-68.90%.
The range of the Intrinsic Value is 165.33 - 890.37 USD
284.51 USD
Intrinsic Value
LLY Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
165.33 - 890.37 |
284.51 |
-68.9% |
| DCF (Growth 10y) |
220.15 - 1,087.56 |
363.35 |
-60.2% |
| DCF (EBITDA 5y) |
103.90 - 176.81 |
137.92 |
-84.9% |
| DCF (EBITDA 10y) |
148.74 - 242.66 |
191.47 |
-79.0% |
| Fair Value |
181.91 - 181.91 |
181.91 |
-80.09% |
| P/E |
163.21 - 274.40 |
238.49 |
-73.9% |
| EV/EBITDA |
99.88 - 405.37 |
230.03 |
-74.8% |
| EPV |
58.58 - 81.25 |
69.91 |
-92.3% |
| DDM - Stable |
119.38 - 740.86 |
430.12 |
-52.9% |
| DDM - Multi |
177.07 - 803.89 |
284.79 |
-68.8% |
LLY Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
868,426.90 |
| Beta |
0.81 |
| Outstanding shares (mil) |
950.43 |
| Enterprise Value (mil) |
894,095.30 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.73% |
| Cost of Debt |
4.25% |
| WACC |
6.65% |